More Articles
Boston Scientific has announced its acquisition of Obsidio, a South Carolina-based medical device company that developed a new…
U.S. Food and Drug Administration (FDA) said cardiovascular devices make up the largest number of technologies accepted into the FDA Breakthrough Devices Program. These devices also make up a large percentage of devices that have made it to final…
New data from the U.S. Census Bureau suggest that cardiovascular disease (CVD) rates in the United States will increase significantly in the years ahead. A team of specialists from…
Patients with peripheral artery disease (PAD) can see considerable benefits if they exercise at a pace that causes discomfort, or even a little pain, in their legs. That takeaway comes from a new analysis published in the Journal…
Researchers have developed a new anticoagulant platform that uses programmable RNA-DNA anticoagulant fibers designed to prevent blood clots without leading to unwanted side effects such as in-hospital bleeding…
Catheter-directed thrombolysis (CDT) is associated with significantly lower short-term mortality rates among submassive pulmonary embolism (PE) patients than anticoagulation alone, according to a new meta-analysis published in the…
Cancer survivors appear to be at significantly higher risk for cardiovascular disease, including heart failure and stroke, according to a …
The U.S. Food and Drug Administration (FDA) has had a busy June, overseeing a…
A new AI-based method to detect plaque erosion using optical coherence tomography (OCT) images offers an opportunity to easily identify a condition that blocks blood flow to the heart and can potentially…
Researchers at the University of Sydney are developing a brand new test that uses blood from a quick pin-prick test to examine a person's risk of heart attack or stroke. …
A Chinese study of over 5,000 high-risk adults, published in …
The Society for Cardiovascular Angiography and Interventions (SCAI) has announced its late-breaking study presentations at its 2022 Scientific Sessions. These key…
Renin-angiotensin-aldosterone system (RAAS) inhibitors can help brain aneurysm patients with high blood pressure reduce their risk of rupture, according to new research published in Hypertension.[1]
…
The U.S. Food and Drug Administration (FDA) has announced that Atrium Medical Corp., a subsidiary of Getinge, is recalling its iCast Covered Stent…
The U.S. Food and Drug Administration (FDA) has been busy in recent weeks,…
In-hospital mortality is improving among high-risk pulmonary embolism (PE) patients, according to new findings published in the American Journal of Cardiology.[1] Systemic thrombolysis (ST) and catheter-directed interventions…
Medtronic has received FDA approval for its IN.PACT 018 Paclitaxel-Coated Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter to treat patients with peripheral arterial disease (PAD) in the superficial femoral and popliteal…
Abbott Medical is recalling multiple lots of its Dragonfly OpStar optical coherence…
Open abdominal aortic aneurysm (AAA) surgical repair is associated with a higher long-term survival rate than endovascular AAA repair (EVAR), according to a new analysis published in JAMA Network Open.[1]
…
Researchers have developed a new imaging-based technique for removing arterial plaque in patients with atherosclerosis, presenting their findings at the 182nd Meeting of the Acoustical Society…